Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
Urology. 2012 Sep;80(3):570-5. doi: 10.1016/j.urology.2012.05.003. Epub 2012 Jun 27.
To assess the feasibility of the nonuse of antimicrobial prophylaxis (AMP) on the incidence of infectious complications after clean category minimally invasive surgery for renal and adrenal tumors.
We evaluated 415 consecutive patients who underwent gasless laparoendoscopic single-port surgery (GasLESS) for renal or adrenal tumors between 2006 and 2010. Forty-two patients with poorly controlled diabetes mellitus, coexisting infection, or opening of the urinary tract during partial nephrectomy were excluded from this study. The remaining 373 patients underwent radical nephrectomy (n = 187), partial nephrectomy (n = 103), or adrenalectomy (n = 83) without AMP. Perioperative infections were categorized into superficial surgical site infection (SSI), deep SSI, and remote infection (RI) and graded using an established 5-grade modification of the original Clavien-Dindo classification system. We investigated the association between the incidence of infectious complications and clinical or perioperative factors.
Infectious complications occurred in 16 cases (4.3%), including 4 superficial SSIs (1.1%), 2 deep SSIs (0.5%), and 10 RIs (2.7%). Neither superficial SSI nor deep SSI was significantly associated with any clinical or perioperative factors. The incidence of RI, however, was associated with longer operative time and higher National Nosocomial Infection Surveillance (NNIS) risk index. All perioperative infections were successfully treated with antibiotics without surgical interventions. No infectious complications equal to or greater than grade IIIa occurred.
The nonuse of AMP and the on-demand use of antibiotics seem to be sufficient for perioperative infectious management in clean category minimally invasive surgery for renal and adrenal tumors.
评估在清洁分类微创肾和肾上腺肿瘤手术中不使用抗菌预防(AMP)对感染性并发症发生率的可行性。
我们评估了 2006 年至 2010 年间 415 例连续接受无气腹腔镜单端口手术(GasLESS)治疗的肾或肾上腺肿瘤患者。排除 42 例糖尿病控制不佳、合并感染或部分肾切除术期间尿路开放的患者。其余 373 例患者接受了无 AMP 的根治性肾切除术(n = 187)、部分肾切除术(n = 103)或肾上腺切除术(n = 83)。围手术期感染分为浅表手术部位感染(SSI)、深部 SSI 和远处感染(RI),并使用原始 Clavien-Dindo 分类系统的 5 级改良进行分级。我们研究了感染性并发症的发生率与临床或围手术期因素之间的关系。
16 例(4.3%)发生感染性并发症,包括 4 例浅表 SSI(1.1%)、2 例深部 SSI(0.5%)和 10 例 RI(2.7%)。浅表 SSI 或深部 SSI 与任何临床或围手术期因素均无显著相关性。然而,RI 的发生率与手术时间较长和国家医院感染监测(NNIS)风险指数较高有关。所有围手术期感染均经抗生素治疗成功,无需手术干预。未发生任何等于或大于 3a 级的感染性并发症。
在清洁分类微创肾和肾上腺肿瘤手术中,不使用 AMP 和按需使用抗生素似乎足以进行围手术期感染管理。